Novartis
NVS
NVS
847 hedge funds and large institutions have $22B invested in Novartis in 2014 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 291 increasing their positions, 342 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.04% less ownership
Funds ownership: 9.82% → 9.79% (-0.04%)
3% less funds holding in top 10
Funds holding in top 10: 60 → 58 (-2)
15% less repeat investments, than reductions
Existing positions increased: 291 | Existing positions reduced: 342
Holders
847
Holding in Top 10
58
Calls
$170M
Puts
$105M
Top Buyers
| 1 | +$422M | |
| 2 | +$101M | |
| 3 | +$72.5M | |
| 4 |
Parnassus Investments
San Francisco,
California
|
+$39.1M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$35.3M |
Top Sellers
| 1 | -$150M | |
| 2 | -$126M | |
| 3 | -$105M | |
| 4 |
BBHC
Brown Brothers Harriman & Co
New York
|
-$89.8M |
| 5 |
IC
Institutional Capital
Chicago,
Illinois
|
-$73.6M |